BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26595078)

  • 1. Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide.
    Castagna L; Bramanti S; Furst S; Giordano L; Sarina B; Crocchiolo R; El-Cheikh J; Granata A; Morabito L; Mauro E; Faucher C; Mohty B; Harbi S; Devillier R; Chabannon C; Carlo-Stella C; Santoro A; Blaise D
    Bone Marrow Transplant; 2016 Mar; 51(3):462-5. PubMed ID: 26595078
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical features of calcineurin inhibitor-induced pain syndrome after allo-SCT.
    Kakihana K; Ohashi K; Murata Y; Tsubokura M; Kobayashi T; Yamashita T; Sakamaki H; Akiyama H
    Bone Marrow Transplant; 2012 Apr; 47(4):593-5. PubMed ID: 21625227
    [No Abstract]   [Full Text] [Related]  

  • 3. Feasibility and Outcome of Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant High-Dose Cyclophosphamide for Children and Adolescents with Hematologic Malignancies: An AIEOP-GITMO Retrospective Multicenter Study.
    Berger M; Lanino E; Cesaro S; Zecca M; Vassallo E; Faraci M; De Bortoli M; Barat V; Prete A; Fagioli F
    Biol Blood Marrow Transplant; 2016 May; 22(5):902-9. PubMed ID: 26860636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of calcineurin inhibitors on sodium excretion in recipients of allogeneic hematopoietic stem cell transplantation.
    Saburi M; Kohashi S; Kato J; Koda Y; Sakurai M; Toyama T; Kikuchi T; Karigane D; Yuda S; Yamane Y; Hashida R; Abe R; Nakazato T; Hirahashi J; Ogata M; Okamoto S; Mori T
    Int J Hematol; 2017 Sep; 106(3):431-435. PubMed ID: 28516402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation.
    Bashey A; Zhang X; Sizemore CA; Manion K; Brown S; Holland HK; Morris LE; Solomon SR
    J Clin Oncol; 2013 Apr; 31(10):1310-6. PubMed ID: 23423745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haploidentical T Cell-Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen-Matched Related or Unrelated Donor.
    Blaise D; Fürst S; Crocchiolo R; El-Cheikh J; Granata A; Harbi S; Bouabdallah R; Devillier R; Bramanti S; Lemarie C; Picard C; Chabannon C; Weiller PJ; Faucher C; Mohty B; Vey N; Castagna L
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):119-24. PubMed ID: 26341397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective comparison of BU-fludarabine and BU-CY regimens in elderly patients or in patients with comorbidities who received unmanipulated haploidentical hematopoietic SCT.
    Sun YQ; Xu LP; Zhang XH; Liu DH; Chen H; Wang Y; Yan CH; Wang JZ; Wang FR; Zhang YY; Liu KY; Huang XJ
    Bone Marrow Transplant; 2015 Apr; 50(4):601-3. PubMed ID: 25599162
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide.
    Castagna L; Crocchiolo R; Furst S; Bramanti S; El Cheikh J; Sarina B; Granata A; Mauro E; Faucher C; Mohty B; Harbi S; Chabannon C; Carlo-Stella C; Santoro A; Blaise D
    Biol Blood Marrow Transplant; 2014 May; 20(5):724-9. PubMed ID: 24530426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target blood concentrations of CYA and tacrolimus in randomized controlled trials for the prevention of acute GVHD after hematopoietic SCT.
    Oshima K; Sato M; Terasako K; Kimura S; Okuda S; Kako S; Kanda Y
    Bone Marrow Transplant; 2010 Apr; 45(4):781-2. PubMed ID: 19701249
    [No Abstract]   [Full Text] [Related]  

  • 10. Favorable outcomes of tacrolimus compared with cyclosporine A for GVHD prophylaxis in HSCT for standard-risk hematological diseases.
    Nasu R; Nannya Y; Shinohara A; Ichikawa M; Kurokawa M
    Ann Hematol; 2014 Jul; 93(7):1215-23. PubMed ID: 24590535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantation.
    Holtick U; Chemnitz JM; Shimabukuro-Vornhagen A; Theurich S; Chakupurakal G; Krause A; Fiedler A; Luznik L; Hellmich M; Wolf D; Hallek M; von Bergwelt-Baildon M; Scheid C
    Eur J Haematol; 2016 Jan; 96(1):27-35. PubMed ID: 25703164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the order of TBI and cyclophosphamide administration on the outcome of allogeneic hematopoietic stem cell transplantation.
    Motohashi K; Fujisawa S; Onizuka M; Kako S; Sakaida E; Shono K; Tatara R; Doki N; Mori T; Sakura T; Aotsuka N; Fuji E; Tomita N; Kawai N; Saitoh T; Usuki K; Taguchi J; Watanabe R; Kobayashi S; Yano S; Kanamori H; Takahashi S; Okamoto S
    Bone Marrow Transplant; 2015 Nov; 50(11):1476-9. PubMed ID: 26191948
    [No Abstract]   [Full Text] [Related]  

  • 13. Painful gynaecomastia secondary to cyclosporine A and tacrolimus in a patient with focal segmental glomerulosclerosis.
    Borrego-Utiel FJ; Pérez-del Barrio Mdel P; Polaina-Rusillo M; Borrego-Hinojosa J
    Nefrologia; 2013 Nov; 33(6):866-7. PubMed ID: 24241383
    [No Abstract]   [Full Text] [Related]  

  • 14. Invasive fungal infection following reduced-intensity cord blood transplantation for adult patients with hematologic diseases.
    Miyakoshi S; Kusumi E; Matsumura T; Hori A; Murashige N; Hamaki T; Yuji K; Uchida N; Masuoka K; Wake A; Kanda Y; Kami M; Tanaka Y; Taniguchi S
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):771-7. PubMed ID: 17580255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired uniparental disomy in chromosome 6p as a feature of relapse after T-cell replete haploidentical hematopoietic stem cell transplantation using cyclophosphamide tolerization.
    Grosso D; Johnson E; Colombe B; Alpdogan O; Carabasi M; Filicko-O'Hara J; Gaballa S; Kasner M; Klumpp T; Martinez-Outschoorn U; Wagner JL; Weiss M; Wang Z; Flomenberg N
    Bone Marrow Transplant; 2017 Apr; 52(4):615-619. PubMed ID: 28067885
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of Outcomes of Hematopoietic Cell Transplants from T-Replete Haploidentical Donors Using Post-Transplantation Cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -DQB1 Allele-Matched Unrelated Donors and HLA-Identical Sibling Donors: A Multivariable Analysis Including Disease Risk Index.
    Bashey A; Zhang X; Jackson K; Brown S; Ridgeway M; Solh M; Morris LE; Holland HK; Solomon SR
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):125-33. PubMed ID: 26359881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose methotrexate may preserve a stronger antileukemic effect than that of cyclosporine after modified donor lymphocyte infusion in unmanipulated haploidentical HSCT.
    Yan CH; Xu LP; Liu DH; Chen H; Wang Y; Wang JZ; Wang FR; Han W; Liu KY; Huang XJ
    Clin Transplant; 2015 Jul; 29(7):594-605. PubMed ID: 25969866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for advanced pediatric malignancies.
    Sawada A; Shimizu M; Isaka K; Higuchi K; Mayumi A; Yoshimoto Y; Kikuchi H; Kondo O; Koyama-Sato M; Yasui M; Kawa K; Inoue M
    Pediatr Hematol Oncol; 2014 Nov; 31(8):754-64. PubMed ID: 25325678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
    Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous cyclosporine and tacrolimus caused anaphylaxis but oral cyclosporine capsules were tolerated in an allogeneic bone marrow transplant recipient.
    Takamatsu Y; Ishizu M; Ichinose I; Ogata K; Onoue M; Kumagawa M; Suzumiya J; Tamura K
    Bone Marrow Transplant; 2001 Aug; 28(4):421-3. PubMed ID: 11571519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.